Archives June 2019

Orgenesis Granted FDA Orphan Drug Designation for Autologous Insulin Producing Cells in the Treatment of Severe Hypoglycemia-Prone Diabetes Resulting from Total Pancreatectomy

Orgenesis, a developer, manufacturer and service provider of advanced cell therapies, announced that the United States Food & Drug Administration (“FDA”) has granted Orphan Drug designation for its Autologous Insulin Producing (“AIP”) cells as a cell replacement therapy for the treatment of severe hypoglycemia-prone diabetes resulting from total pancreatectomy (“TP”) due to chronic pancreatitis (“CP”).

Read More


Studies Uncover New Approaches to Combat Hair Loss in Men and Women

Two recent studies highlight novel ways to combat pattern hair loss in men and women using small molecules such as JAK inhibitors that reawaken dormant hair follicles, as well as stem cell therapies aimed at growing new follicles.  In the first study, researchers led by Angela Christiano, PhD, the Richard & Mildred Rhodebeck Professor of Dermatology at

Read More


Mesenchymal Stem Cells Empowering Tendon Regenerative Therapies

Tendon tissues have limited healing capacity. The incidence of tendon injuries and the unsatisfactory functional outcomes of tendon repair are driving the search for alternative therapeutic approaches envisioning tendon regeneration. Cellular therapies aim at delivering adequate, regeneration-competent cell types to the injured tendon and toward ultimately promoting its reconstruction and recovery of functionality. Mesenchymal stem

Read More


Unproven stem cell therapies often peddled by doctors without training

At U.S. clinics advertising unproven stem cell treatments, roughly two-thirds of the clinicians may be physicians, but a new study suggests these doctors are often trained in specialties unrelated to the services they provide. “About half of the companies we examined offer unproven stem cell treatments for conditions (for) which they do not have a

Read More


With a Focus on DLP: Researchers 3D Printing High Resolution Tricalcium Phosphate Scaffolds for Bone Regeneration

In ‘Application of high resolution DLP stereolithography for fabrication of tricalcium phosphate scaffolds for bone regeneration,’ researchers examine how to make complex, stable scaffolds based on β-tricalcium. Typically, there are obstacles to finding materials and techniques suitable for creating structures capable of sustaining cell life. Here, the authors are aware of the necessities in tissue

Read More